This study will evaluate the impact of Short Message Service (SMS) on compliance with surveillance of patients with germ-cell tumors. Patients will be randomized in a 2:1 ratio to get 2 groups : (1) patients will receive reminder SMS before appointment detailing the date of consultation and exams to be performed before; (2) standard of care without SMS.
Study Type
OBSERVATIONAL
Enrollment
235
short message service
CHU Besancon
Besançon, Franche-Comté, France
RECRUITINGRate of patients who report optimal compliance to surveillance
Optimal compliance is defined according to the following 2 parameters: * The patient comes to all the appointments, on the expected day, AND * With all the biological and imaging exams previously scheduled by the physician.
Time frame: 1 year
Rate of patients who report intermediate compliance to surveillance
Intermediate compliance is defined according to the following 2 parameters: * The patient comes to all the appointments, but in one of the consultations, he delays his scheduled appointment of more than 3 weeks but less than 6 weeks OR * Missing a biological or imaging exam.
Time frame: 1 year
Rate of patients who report a non compliance to surveillance
Non compliance is defined according to the following 3 parameters: The patient misses a consultation, without warning, OR * He delays of more than 6 weeks his appointment of consultation, OR * At least 2 biological or imaging exams requested by the oncologist are missing from all consultations.
Time frame: 1 year
Patient satisfaction of sending SMS, in experimental arm
It is evaluated with the following question: do you find that having reminder sms for your appointments and exams is useful? evaluated on a scale of 0 to 10 (0: useless, 10: useful)
Time frame: 1 year
biological recurrence rate
Biological recurrence rate is defined by the increase in tumor markers (alpha-fetoprotein, lactic dehydrogenase, human chorionic gonadotropin).
Time frame: 1 year
Radiological recurrence rate
Radiological recurrence rate is defined according to Response evaluation criteria in solid tumors (RECIST) criteria 1.1.
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.